Protecting HOME Access Act of 2017

Issues related to lung disease treatment, prevention and research; public health; Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to the President's Budget; H.R.774 Medicaid Coverage of Tobacco Cessation Nonprescription Drugs Act H.R.1121 Pre-existing Conditions Protection Act of 2017; H.R.2550 Medicare Telehealth Parity Act of 2017; H.R.4695 Bipartisan Market Stabilization and Innovation Act of 2017; H.R.4897 Women and Lung Cancer Research and Preventive Services Act of 2018; S.974 CREATES Act of 2017; S.1462 Marketplace Certainty Act; S.2494 Fair Care Act; S.2507 Improving Choices in Health Care Coverage Act; S. 2507, Improving Choices in Health Care Coverage Act (Codification of Short Term Limited Duration Health Plans); H.Con.Res.128 - Establishing the congressional budget for the United States Government for fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028 H.R.2 Agriculture and Nutrition Act of 2018; S.3388 - Ensuring Coverage for Patients with Pre-Existing Conditions Act; H.R.4229 - Protecting HOME Access Act of 2017; S.J.Res.63 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury, Secretary of Labor, and Secretary of Health and Human Services relating to "Short-Term, Limited Duration Insurance

Client expense: $100,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA), White House Office

H.R. 4229; DME Fee schedule.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

HR 7217 the IMPROVE Act, S 486, HR 750, HR 4229, CMS-1687-IFC Durable Medical Equipment Fee Schedule adjustments, Implementation of Medicaid cuts for Durable Medical Equipment in the 21st Century Cures law to protect Complex Rehabilitation Technology (CRT), CMS proposed CY2019 proposed rule (CMS-1691-P) to protect access for patients with severe disabilities.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to the home healthcare equipment market. Issues related to Medicare reimbursement levels. Issues related to CMS and DME rulemaking. Issues related to the implementation of H.R. 24, the 21st Century Cures Act. Issues related to competitive bidding reform. Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas." Issues related to H.R. 4229, the Protecting Home Oxygen & Medical Equipment (HOME) Access Act of 2017.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 3730 to Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; S. 486 Protecting Beneficiary Access to Complex Rehab Technology Act of 2017 and H.R. 1361 to Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative manual wheelchairs and accessories; H.R. 4229 Protecting HOME Access Act of 2017.

Client expense: Not reported · Firm income: $45,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); The IMPROVE Act; H.R. 7217; Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and CMS ESRD/DEMPOS proposed and final rules.

Client expense: Not reported · Firm income: $45,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); H.R. 7217 - The IMPROVE Act, all provisions; Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and CMS ESRD/DEMPOS proposed and final rules.

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R. 4229; DME Fee schedule.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to lung disease treatment, prevention and research; public health; Issues related to tobacco cessation; Issues related to the President's Budget; Issues related to Medicaid waivers; Issues related to the Affordable Care Act; Issues related to oxygen; Issues related to access to healthcare; H.R.2550, Medicare Telehealth Parity Act of 2017; H.R.4229, Protecting HOME Access Act of 2017;H.R.4667, H.R.4695, Bipartisan Market Stabilization and Innovation Act of 2017 S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019;

Client expense: $90,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA), White House Office

Telemonitoring; competitive bidding; H.R. 4229; Interim Final Rule on DMEPOS; Sunshine Act/opioids (H.R. 6)

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1361, S 486, HR 750, HR 4229, CMS-1687-IFC Durable Medical Equipment Fee Schedule adjustments, Implementation of Medicaid cuts for Durable Medical Equipment in the 21st Century Cures law to protect Complex Rehabilitation Technology (CRT), CMS proposed CY2019 proposed rule (CMS-1691-P) to protect access for patients with severe disabilities.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

House Bills H.R. 50, the Unfunded Mandates Information and Transparency Act of 2017 - Support H.R. 1150, Tanning Tax Repeal Act of 2017 - Support H.R. 3798, Save American Workers Act - Support H.R. 4229, Protecting HOME Access Act of 2017 - Support H.R. 4616, Employer Relief Act of 2018 - Support H.R. 5948, Small Carrier Electronic Logging Device Exemption Act of 2018 - Support H.R. 6277, Main Street Tax Certainty Act - Support H.R. 6311, Increasing Access to Lower Premiums Plans and Expanding Health Savings Account Act of 2018 - Support H.R. 6760, Protecting Family and Small Business Tax Cuts of 2018 - Support Senate Bills S. 2687, A bill to amend the Internal Revenue Code of 1986 to make permanent the individual tax provisions of the tax reform law - Support Endangered Species Act Amendments of 2018 - Support Testimony William Dunkelberg, NFIB, The Positive Economic Growth Effects of the Tax Cuts and Jobs Act, Joint Economic Committee. September 6, 2018. Comments Comments on IRS Notice of Proposed Rulemaking titled "Qualified Business Income Deduction," REG-107892-18, 83 Fed. Reg. 40884 (August 16, 2018) Other Issues Health Insurance Tax (HIT) Project Labor Agreements (PLAs) Nomination to the National Labor Relations Board (NLRB) Tax treatment of capital gains

Client expense: $1,019,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), SENATE, Small Business Administration (SBA), Treasury, Dept of

DMEPOS; Medicare reform; HR 4229

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress) ; DME issues in the FY2019 President's Budget and ESRD/DEMPOS proposed rule.

Client expense: Not reported · Firm income: $45,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)

H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 3730 to Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; S. 486 Protecting Beneficiary Access to Complex Rehab Technology Act of 2017 and H.R. 1361 to Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative manual wheelchairs and accessories; H.R. 4229 Protecting HOME Access Act of 2017.

Client expense: Not reported · Firm income: $45,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 3730 to Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; S. 486 Protecting Beneficiary Access to Complex Rehab Technology Act of 2017 and H.R. 1361 to Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative manual wheelchairs and accessories; H.R. 4229 Protecting HOME Access Act of 2017.

Client expense: Not reported · Firm income: $15,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

Issues related to the home healthcare equipment market. Issues related to Medicare reimbursement levels. Issues related to CMS and DME rulemaking. Issues related to the implementation of H.R. 24, the 21st Century Cures Act. Issues related to competitive bidding reform. Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas." Issues related to H.R. 4229, the Protecting Home Oxygen & Medical Equipment (HOME) Access Act of 2017.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and ESRD/DEMPOS proposed rule.

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Telemonitoring; competitive bidding; H.R. 4229; Interim Final Rule on DMEPOS.

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4229; DME Fee schedule.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to lung disease treatment, prevention and research; public health; Issues related to tobacco cessation; Issues related to the President's Budget; Issues related to Medicaid waivers; Issues related to the Affordable Care Act; H.R.2550, Medicare Telehealth Parity Act of 2017; H.R.4229, Protecting HOME Access Act of 2017;H.R.4667, H.R.4695, Bipartisan Market Stabilization and Innovation Act of 2017 S.1835, Lower Premiums Through Reinsurance Act of 2017; S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019;

Client expense: $50,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA), White House Office

Discussions regarding protected classes reform Part B drug coverage and Payment reform Massachusetts 1115 Medicaid waiver amendment FDA Regulatory Review Opioid Substance Abuse legislation Medicare Part D Coverage Gap provisions in Bipartisan Budget Act President's Drug Pricing Blueprint H.R.4229, DME Payments for Home Care

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and ESRD/DEMPOS proposed rule.

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress) ; DME issues in the FY2019 President's Budget and ESRD/DEMPOS proposed rule.

Client expense: Not reported · Firm income: $15,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)

H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 3730 to Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; S. 486 Protecting Beneficiary Access to Complex Rehab Technology Act of 2017 and H.R. 1361 to Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative manual wheelchairs and accessories; H.R. 4229 Protecting HOME Access Act of 2017.

Client expense: Not reported · Firm income: $15,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

DMEPOS; Medicare reform; HR 4229

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 4229; Medicare reimbursement; DMEPOS

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to the home healthcare equipment market. Issues related to Medicare reimbursement levels. Issues related to CMS and DME rulemaking. Issues related to the implementation of H.R. 24, the 21st Century Cures Act. Issues related to competitive bidding reform. Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas." Issues related to H.R. 4229, the Protecting Home Oxygen & Medical Equipment (HOME) Access Act of 2017.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1361, S 486, HR 750, HR 4229, CMS-1687-IFC Durable Medical Equipment Fee Schedule adjustments, Implementation of Medicaid cuts for Durable Medical Equipment in the 21st Century Cures law to protect Complex Rehabilitation Technology (CRT), CMS proposed CY2019 proposed rule (CMS-1691-P) to protect access for patients with severe disabilities.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 3730 To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; S. 486 Protecting Beneficiary Access to Complex Rehab Technology Act of 2017 and H.R. 1361 To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative manual wheelchairs and accessories; H.R. 4229 Protecting HOME Access Act of 2017

Client expense: $77,160 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and ESRD/DEMPOS proposed rule.

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare, DME bidding, audits; HR750 Ensuring Access to Quality Complex Rehab Technology Act HR1361/S486, HR3730 non-application of comp bidding rates to complex rehab accessories (Protecting Beneficiary Access to CRT Act of 2017); cuts in non-bid areas; Cures Act (HR6/HR34 114th Congress); complex rehab technology accessories comp bidding; HR2445 DMEPOS Access & Transparency Act of 2017; HR4229 Protecting HOME Access Act; HR2550 Medicare Telehealth Parity Act; HR1625 Appropriations Act of 2018; CMS IFR re non bid area relief for DME; expanding & making permanent Medicare power mobility device demo; Audit & Appeal Fairness, Integrity & Reforms in Medicare Act (S2368 114th Congress); DME issues in FY2019 Pres Budget

Client expense: Not reported · Firm income: Not reported

Medicare, DME bidding, audits; HR750 Ensuring Access to Quality Complex Rehab Technology Act HR1361/S486, HR3730 non-application of comp bidding rates to complex rehab accessories (Protecting Beneficiary Access to CRT Act of 2017); cuts in non-bid areas; Cures Act (HR6/HR34 114th Congress); complex rehab technology accessories comp bidding; HR2445 DMEPOS Access & Transparency Act of 2017; HR4229 Protecting HOME Access Act; HR2550 Medicare Telehealth Parity Act; HR1625 Appropriations Act of 2018; CMS IFR re non bid area relief for DME; expanding & making permanent Medicare power mobility device demo; Audit & Appeal Fairness, Integrity & Reforms in Medicare Act (S2368 114th Congress); DME issues in FY2019 Pres Budget

Client expense: Not reported · Firm income: Not reported

Medicare, DME bidding, audits; HR750 Ensuring Access to Quality Complex Rehab Technology Act HR1361/S486, HR3730 non-application of comp bidding rates to complex rehab accessories (Protecting Beneficiary Access to CRT Act of 2017); cuts in non-bid areas; Cures Act (HR6/HR34 114th Congress); complex rehab technology accessories comp bidding; HR2445 DMEPOS Access & Transparency Act of 2017; HR4229 Protecting HOME Access Act; HR2550 Medicare Telehealth Parity Act; HR1625 Appropriations Act of 2018; CMS IFR re non bid area relief for DME; expanding & making permanent Medicare power mobility device demo; Audit & Appeal Fairness, Integrity & Reforms in Medicare Act (S2368 114th Congress); DME issues in FY2019 Pres Budget

Client expense: Not reported · Firm income: Not reported

H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 3730 To Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; S. 486 Protecting Beneficiary Access to Complex Rehab Technology Act of 2017 and H.R. 1361 To Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative manual wheelchairs and accessories; H.R. 4229 Protecting HOME Access Act of 2017.

Client expense: Not reported · Firm income: Not reported

H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 3730 To Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; S. 486 Protecting Beneficiary Access to Complex Rehab Technology Act of 2017 and H.R. 1361 To Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative manual wheelchairs and accessories; H.R. 4229 Protecting HOME Access Act of 2017.

Client expense: Not reported · Firm income: Not reported

H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 3730 To Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; S. 486 Protecting Beneficiary Access to Complex Rehab Technology Act of 2017 and H.R. 1361 To Amend Title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative manual wheelchairs and accessories; H.R. 4229 Protecting HOME Access Act of 2017.

Client expense: Not reported · Firm income: Not reported

Issues related to lung disease treatment, prevention and research; public health; Issues related to tobacco cessation; Issues related to the President's Budget; Issues related to Medicaid waivers; Issues related to the Affordable Care Act; H.R.2550, Medicare Telehealth Parity Act of 2017; H.R.4229, Protecting HOME Access Act of 2017; H.R.4695, Bipartisan Market Stabilization and Innovation Act of 2017; S.1827, KIDS Act of 2017; S.1835, Lower Premiums Through Reinsurance Act of 2017;.

Client expense: $260,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, Veterans Affairs, Dept of (VA), White House Office

HR 1361, S 486, HR 750, HR 4229, CMS-1687-IFC Durable Medical Equipment Fee Schedule adjustments, Implementation of Medicaid cuts for Durable Medical Equipment in the 21st Century Cures law to protect Complex Rehabilitation Technology (CRT).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R. 4229; DME Fee schedule.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Telemonitoring; competitive bidding; H.R. 4229; Interim Final Rule on DMEPOS.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the home healthcare equipment market. Issues related to Medicare reimbursement levels. Issues related to CMS and DME rulemaking. Issues related to the implementation of H.R. 24, the 21st Century Cures Act. Issues related to competitive bidding reform. Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas." Issues related to H.R. 4229, the Protecting Home Oxygen & Medical Equipment (HOME) Access Act of 2017.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE